Abbott ABT Diagnostic Products — Depreciation
Other segment segments
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's diagnostic products — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Abbott's diagnostic products — depreciation?
- Abbott (ABT) reported diagnostic products — depreciation of $144M in Q1 2026.
- How has Abbott's diagnostic products — depreciation changed year-over-year?
- Abbott's diagnostic products — depreciation increased by 14.3% year-over-year, from $126M to $144M.
- What is the long-term trend for Abbott's diagnostic products — depreciation?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — depreciation has grown at a -8.5% compound annual growth rate (CAGR), from $760M to $533M.
- What does diagnostic products — depreciation mean?
- The annual non-cash cost of using up physical assets like machinery.
- How do you interpret diagnostic products — depreciation?
- Changes reflect the age and scale of the segment's capital infrastructure and investment cycle.
- How does diagnostic products — depreciation compare across companies?
- Standard accounting metric for capital-intensive businesses.